73 related articles for article (PubMed ID: 7893448)
21. Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate.
Chakrabarti BK; Ling X; Yang ZY; Montefiori DC; Panet A; Kong WP; Welcher B; Louder MK; Mascola JR; Nabel GJ
Vaccine; 2005 May; 23(26):3434-45. PubMed ID: 15837367
[TBL] [Abstract][Full Text] [Related]
22. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.
Smith DM; Strain MC; Frost SD; Pillai SK; Wong JK; Wrin T; Liu Y; Petropolous CJ; Daar ES; Little SJ; Richman DD
Virology; 2006 Nov; 355(1):1-5. PubMed ID: 16962152
[TBL] [Abstract][Full Text] [Related]
23. Autologous neutralizing antibodies and viral load in HIV-2-infected individuals.
Tamalet C; Simon F; Dhiver C; Matheron S; de Micco P; Gastao JA; Brun-Vézinet F
AIDS; 1995 Jan; 9(1):90-1. PubMed ID: 7893447
[No Abstract] [Full Text] [Related]
24. Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1.
Donners H; Willems B; Beirnaert E; Colebunders R; Davis D; van der Groen G
AIDS; 2002 Feb; 16(3):501-3. PubMed ID: 11834970
[No Abstract] [Full Text] [Related]
25. HIV-1 binding and neutralizing antibodies of injecting drug users.
Ouverney EP; Teixeira SL; Silva-de-Jesus C; Hacker MA; Morgado MG; Bastos FI; Bongertz V
Braz J Med Biol Res; 2005 Sep; 38(9):1313-20. PubMed ID: 16138213
[TBL] [Abstract][Full Text] [Related]
26. Complement-mediated, antibody-dependent neutralizing titers of sera from asymptomatic and symptomatic HIV-infected individuals.
Spear GT; Carlson JR; Jennings MB; Takefman DM; Landay AL
AIDS; 1992 Sep; 6(9):1047. PubMed ID: 1388899
[No Abstract] [Full Text] [Related]
27. Antibody and B-cell responses may control circulating lipopolysaccharide in patients with HIV infection.
Lim A; Amini A; D'Orsogna LJ; Rajasuriar R; Kramski M; Lewin SR; Purcell DF; Price P; French MA
AIDS; 2011 Jul; 25(11):1379-83. PubMed ID: 21572302
[TBL] [Abstract][Full Text] [Related]
28. Research. 'Superinfected' have more potent antibody response to HIV.
AIDS Policy Law; 2012 May; 27(6):3. PubMed ID: 22655314
[No Abstract] [Full Text] [Related]
29. Study describes onset of broadly neutralizing antibody responses in HIV-infected individuals.
von Bubnoff A
IAVI Rep; 2011; 15(1):23. PubMed ID: 21449508
[No Abstract] [Full Text] [Related]
30. HIV antibodies and athletes.
Griffiths PD
Rev Med Virol; 2012 Jul; 22(4):211-3. PubMed ID: 22653795
[No Abstract] [Full Text] [Related]
31. The role of the humoral immune response in HIV infection.
Fenyö EM; Albert J; McKeating J
AIDS; 1996; 10 Suppl A():S97-106. PubMed ID: 8883616
[No Abstract] [Full Text] [Related]
32. Importance of anti-HIV-1 antibodies.
Karpas A; Ash S; Bainbridge D
Nat Med; 1997 Jun; 3(6):590-1. PubMed ID: 9176475
[No Abstract] [Full Text] [Related]
33. Human monoclonal antibodies to HIV-1 define synergistic activities leading to enhanced neutralization.
Zolla-Pazner S; Laal S; Burda S; Buchbinder A
Antibiot Chemother (1971); 1994; 46():38-47. PubMed ID: 7826038
[No Abstract] [Full Text] [Related]
34. Longitudinal study of serum neutralization of HIV-1 in infected plasma donors.
Abelian AV; Saurya S; Ash S; Karpas A
J Med Virol; 2001 Dec; 65(4):649-58. PubMed ID: 11745927
[TBL] [Abstract][Full Text] [Related]
35. Inefficacy of neutralizing antibodies against autologous lymph-node HIV-1 isolates in patients with early-stage HIV infection.
Tamalet C; Lafeuillade A; Tourres C; Yahi N; Vignoli C; De Micco P
AIDS; 1994 Mar; 8(3):388-9. PubMed ID: 8031520
[No Abstract] [Full Text] [Related]
36. Infection with human immunodeficiency virus type 1 among leprosy patients in Zaire.
Lucas SB; Fine PE; Sterne JA; Pönnighaus JM; Turner AC; De Cock KM; Zuckerman M
J Infect Dis; 1995 Feb; 171(2):502-4. PubMed ID: 7844401
[No Abstract] [Full Text] [Related]
37. Antibody in human immunodeficiency virus infection.
Brunell PA
Ann N Y Acad Sci; 1993 Oct; 693():9-13. PubMed ID: 8267297
[No Abstract] [Full Text] [Related]
38. Identifying broadly neutralizing antibody activity in HIV-infected individuals.
Kresge KJ
IAVI Rep; 2009; 13(3):18. PubMed ID: 20214321
[No Abstract] [Full Text] [Related]
39. Synergy determination issues.
Chou TC
J Virol; 2002 Oct; 76(20):10577; author reply 10578. PubMed ID: 12239339
[No Abstract] [Full Text] [Related]
40. Detection of HIV-1 antibody in urine specimens in a region of low HIV-1 prevalence.
Longshore D; Anglin MD; Annon TA; Fukui P; Asch J
J Acquir Immune Defic Syndr (1988); 1992; 5(9):947-9. PubMed ID: 1512695
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
